Briseis Aschebrook-Kilfoy1, Benjamin James2, Sapna Nagar3, Sharone Kaplan2, Vanessa Seng2, Habibul Ahsan1, Peter Angelos2, Edwin L Kaplan2, Marlon A Guerrero4, Jennifer H Kuo5, James A Lee5, Elliot J Mitmaker6, Jacob Moalem7, Daniel T Ruan8, Wen T Shen9, Raymon H Grogan2. 1. 1 Department of Public Health Sciences, The University of Chicago , Chicago, Illinois. 2. 2 Endocrine Surgery Research Program, Department of Surgery, Pritzker School of Medicine, The University of Chicago , Chicago, Illinois. 3. 3 Division of Endocrine Surgery, Department of General Surgery, Beaumont Hospitals, Oakland University William Beaumont School of Medicine , Royal Oak, Michigan. 4. 4 Department of Surgery, University of Arizona School of Medicine , Tucson, Arizona. 5. 5 Division of GI/Endocrine Surgery, Department of Surgery, Columbia University Medical Center , New York, New York. 6. 6 Department of Surgery and Oncology, University of Rochester Medical Center School of Medicine and Dentistry , Rochester, New York. 7. 7 Department of Surgery, McGill University Health Centre , Montreal, Canada . 8. 8 Department of Surgery, Brigham and Women's Hospital , Boston, Massachusetts. 9. 9 Department of Surgery, University of California , San Francisco, San Francisco, California.
Abstract
BACKGROUND: The prevalence of thyroid cancer survivors is rising rapidly due to the combination of an increasing incidence, high survival rates, and a young age at diagnosis. The physical and psychosocial morbidity of thyroid cancer has not been adequately described, and this study therefore sought to improve the understanding of the impact of thyroid cancer on quality of life (QoL) by conducting a large-scale survivorship study. METHODS: Thyroid cancer survivors were recruited from a multicenter collaborative network of clinics, national survivorship groups, and social media. Study participants completed a validated QoL assessment tool that measures four morbidity domains: physical, psychological, social, and spiritual effects. Data were also collected on participant demographics, medical comorbidities, tumor characteristics, and treatment modalities. RESULTS: A total of 1174 participants with thyroid cancer were recruited. Of these, 89.9% were female, with an average age of 48 years, and a mean time from diagnosis of five years. The mean overall QoL was 5.56/10, with 0 being the worst. Scores for each of the sub-domains were 5.83 for physical, 5.03 for psychological, 6.48 for social, and 5.16 for spiritual well-being. QoL scores begin to improve five years after diagnosis. Female sex, young age at diagnosis, and lower educational attainment were highly predictive of decreased QoL. CONCLUSION: Thyroid cancer diagnosis and treatment can result in a decreased QoL. The present findings indicate that better tools to measure and improve thyroid cancer survivor QoL are needed. The authors plan to follow-up on these findings in the near future, as enrollment and data collection are ongoing.
BACKGROUND: The prevalence of thyroid cancer survivors is rising rapidly due to the combination of an increasing incidence, high survival rates, and a young age at diagnosis. The physical and psychosocial morbidity of thyroid cancer has not been adequately described, and this study therefore sought to improve the understanding of the impact of thyroid cancer on quality of life (QoL) by conducting a large-scale survivorship study. METHODS:Thyroid cancer survivors were recruited from a multicenter collaborative network of clinics, national survivorship groups, and social media. Study participants completed a validated QoL assessment tool that measures four morbidity domains: physical, psychological, social, and spiritual effects. Data were also collected on participant demographics, medical comorbidities, tumor characteristics, and treatment modalities. RESULTS: A total of 1174 participants with thyroid cancer were recruited. Of these, 89.9% were female, with an average age of 48 years, and a mean time from diagnosis of five years. The mean overall QoL was 5.56/10, with 0 being the worst. Scores for each of the sub-domains were 5.83 for physical, 5.03 for psychological, 6.48 for social, and 5.16 for spiritual well-being. QoL scores begin to improve five years after diagnosis. Female sex, young age at diagnosis, and lower educational attainment were highly predictive of decreased QoL. CONCLUSION:Thyroid cancer diagnosis and treatment can result in a decreased QoL. The present findings indicate that better tools to measure and improve thyroid cancer survivor QoL are needed. The authors plan to follow-up on these findings in the near future, as enrollment and data collection are ongoing.
Authors: Olga Husson; Harm R Haak; Wilma A Oranje; Floortje Mols; Peter H M Reemst; Lonneke V van de Poll-Franse Journal: Clin Endocrinol (Oxf) Date: 2011-10 Impact factor: 3.478
Authors: Nancy L Cho; Jacob Moalem; Lily Chen; Carrie C Lubitz; Francis D Moore; Daniel T Ruan Journal: Endocr Pract Date: 2014-05 Impact factor: 3.443
Authors: Briseis A Kilfoy; Tongzhang Zheng; Theodore R Holford; Xuesong Han; Mary H Ward; Andreas Sjodin; Yaqun Zhang; Yana Bai; Cairong Zhu; Grace L Guo; Nathaniel Rothman; Yawei Zhang Journal: Cancer Causes Control Date: 2008-11-19 Impact factor: 2.506
Authors: April Mendoza; Brian Shaffer; Daniel Karakla; M Elizabeth Mason; David Elkins; Thomas E Goffman Journal: Thyroid Date: 2004-02 Impact factor: 6.568
Authors: Susanne Singer; Thomas Lincke; Eva Gamper; Krishnan Bhaskaran; Stefan Schreiber; Andreas Hinz; Thomas Schulte Journal: Thyroid Date: 2011-12-22 Impact factor: 6.568
Authors: Jithma Prasad Abeykoon; Luke Mueller; Frank Dong; Ashish V Chintakuntlawar; Jonas Paludo; Rami Mortada Journal: Horm Cancer Date: 2016-04-21 Impact factor: 3.869
Authors: Reese W Randle; Norah M Bushman; Jason Orne; Courtney J Balentine; Elizabeth Wendt; Megan Saucke; Susan C Pitt; Cameron L Macdonald; Nadine P Connor; Rebecca S Sippel Journal: Thyroid Date: 2017-06-12 Impact factor: 6.568
Authors: Megan K Applewhite; Benjamin C James; Sharone P Kaplan; Peter Angelos; Edwin L Kaplan; Raymon H Grogan; Briseis Aschebrook-Kilfoy Journal: World J Surg Date: 2016-03 Impact factor: 3.352